The 4th JAK Inhibitors Drug Development Summit is dedicated to new JAK inhibitor therapeutics for dermatologic, autoimmune, oncologic and other inflammatory indications.
Topics
- Current & Future State of the JAK Inhibitor Landscape
- JAK Inhibitor Formulation & Drug Delivery Systems
- How to Measure JAK Safety Against Practicality - Weighing the Benefit-Risk
- JAK Selectivity in the Push Towards Precise Medical Approaches
- Future Horizons: Best Prepare Your JAK Inhibitor Pipelines
Who should Attend
Senior attendees from pharma, biotech and academia.
